Vimarsana
Biggest News Aggregation in the World

Page 33 - Ace2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ace2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ace2 Today - Breaking & Trending Today

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains - Vimarsana News

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

A research paper recently uploaded to the preprint server bioRxiv by Dominguez-Vega et al. (23rd Feb, 2021) describes an in-depth structural analysis of the RBD of the spike protein expressed in mammalian Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells, providing a new understanding of protein structure and function.

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells - Vimarsana News

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells The clinical phenotype of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor...

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies - Vimarsana News

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

A new research paper recently uploaded to the preprint server bioRxiv by Jesse D. Bloom et al. (22nd Feb 2021) aims to map all of the currently circulating SARS-CoV-2 lineages with resistance towards LY-CoV555 and LY-CoV016, and document the specific mutations that confer resistance, ultimately suggesting that future monoclonal antibody cocktails should target a more diverse range of epitopes.

Research predicts which mammal species can spread SARS-CoV-2 - Vimarsana News

Research predicts which mammal species can spread SARS-CoV-2

Scientists worldwide are fighting to contain the ongoing COVID-19 pandemic, which has already claimed more than 2.48 million lives. Preventing spillback infections is essential to containing the pandemic. To do so, it is vital to understand the nature of the virus, i.e., its susceptibility to a range of hosts.

Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants - Vimarsana News

Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants

By analyzing the cryoEM structures of antibodies against the SARS-CoV-2 virus, researchers report that the neutralizing capabilities of two antibodies are not affected by new strains as these antibodies target regions of the virus away from the ACE2 binding regions.